Rabin Medical Center, Beilinson Hospital, — Petah Tikva

Public research footprint of Rabin Medical Center, Beilinson Hospital,, compiled from the ClinicalTrials.gov public registry.

118

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute… · Advanced Non-small Cell Lung Cancer · Relapsed Diffuse Large B-Cell Lymphoma · Clostridium Difficile Infection Recurrence

Recently updated registry entries

NCT06016842 — A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis (Recruiting)
NCT06237452 — VE303 for Prevention of Recurrent Clostridioides Difficile Infection (Recruiting)
NCT03975647 — A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1)… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Rabin Medical Center, Beilinson Hospital,?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.